New Insights into the PPARγAgonists for the Treatment of Diabetic Nephropathy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Insights into the PPARγAgonists for the Treatment of Diabetic Nephropathy
Authors
Keywords
-
Journal
PPAR Research
Volume 2014, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2014-01-30
DOI
10.1155/2014/818530
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- L-165,041, troglitazone and their combination treatment to attenuate high glucose-induced receptor for advanced glycation end products (RAGE) expression
- (2013) Yao-Jen Liang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6
- (2013) Riyaz Mohamed et al. LABORATORY INVESTIGATION
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- PPARγAgonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice
- (2013) Ying Sun et al. PPAR Research
- Mitochondrial Fission Triggered by Hyperglycemia Is Mediated by ROCK1 Activation in Podocytes and Endothelial Cells
- (2012) Wenjian Wang et al. Cell Metabolism
- Thiazolidinedione safety
- (2012) Jacqueline Kung et al. Expert Opinion On Drug Safety
- Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy
- (2012) E. Jennifer Weil et al. KIDNEY INTERNATIONAL
- Impact of high glucose and transforming growth factor–β on bioenergetic profiles in podocytes
- (2012) Nicole Stieger et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (γ) Agonist
- (2012) R. Agrawal et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?
- (2012) Pitchai Balakumar et al. PHARMACOLOGICAL RESEARCH
- PPARs: Fatty acid sensors controlling metabolism
- (2012) Lars la Cour Poulsen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Thiazolidinediones and PPARγ agonists: time for a reassessment
- (2012) Bertrand Cariou et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Podocytopathy in Diabetes: A Metabolic and Endocrine Disorder
- (2011) Ana Diez-Sampedro et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Mitochondrial Dysfunction Mediates Aldosterone-Induced Podocyte Damage
- (2011) Chunhua Zhu et al. AMERICAN JOURNAL OF PATHOLOGY
- PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases
- (2011) Jichun Yang et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Microsomal Prostaglandin E Synthase 1 Deletion Retards Renal Disease Progression But Exacerbates Anemia in Mice With Renal Mass Reduction
- (2011) Zhanjun Jia et al. HYPERTENSION
- Podocyte COX-2 Exacerbates Diabetic Nephropathy by Increasing Podocyte (Pro)renin Receptor Expression
- (2011) H. Cheng et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- PPAR 2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies
- (2011) S. De Cosmo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cyclooxygenase-2 and kidney failure
- (2011) Amelia Rios et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- The Podocyte in Diabetic Kidney Disease
- (2011) Erin Stitt-Cavanagh et al. TheScientificWorldJOURNAL
- Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis
- (2010) Pantelis A. Sarafidis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Synthesis and biological activities of novel indole derivatives as potent and selective PPARγ modulators
- (2010) Yann Lamotte et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury
- (2010) Gianluca Miglio et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nitro-Oleic Acid Inhibits Angiotensin II–Induced Hypertension
- (2010) Jifeng Zhang et al. CIRCULATION RESEARCH
- Effects of PPARγ on hypertension, atherosclerosis, and chronic kidney disease
- (2010) Akira Sugawara et al. ENDOCRINE JOURNAL
- The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy
- (2010) Mandeep Kumar Arora et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pioglitazone: side effect and safety profile
- (2010) Priya Shah et al. Expert Opinion On Drug Safety
- Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents
- (2010) Lalit S Doshi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- mPGES-1 Protects Against DOCA-Salt Hypertension via Inhibition of Oxidative Stress or Stimulation of NO/cGMP
- (2010) Zhanjun Jia et al. HYPERTENSION
- Covalent Peroxisome Proliferator-activated Receptor γ Adduction by Nitro-fatty Acids
- (2010) Francisco J. Schopfer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Maladaptive Role for EP4 Receptors in Podocytes
- (2010) E. M. Stitt-Cavanagh et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis
- (2010) Zhanjun Jia et al. KIDNEY INTERNATIONAL
- Renal PPARγ mRNA expression increases with impairment of renal function in patients with chronic kidney disease
- (2010) JULIA LEPENIES et al. NEPHROLOGY
- PPARγ and chronic kidney disease
- (2010) Agnes B. Fogo PEDIATRIC NEPHROLOGY
- Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats
- (2010) Haiping Wang et al. PPAR Research
- The effect of PPAR-α agonism on apolipoprotein metabolism in humans
- (2009) Ashish Shah et al. ATHEROSCLEROSIS
- Nrf2-dependent and -independent Responses to Nitro-fatty Acids in Human Endothelial Cells
- (2009) Emilia Kansanen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tesaglitazar, a Dual Peroxisome Proliferator- Activated Receptor Agonist (PPARα/γ), Improves Metabolic Abnormalities and Reduces Renal Injury in Obese Zucker Rats
- (2009) Jie Liao et al. NEPHRON EXPERIMENTAL NEPHROLOGY
- Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease
- (2009) Emma Robinson et al. PHARMACOLOGY & THERAPEUTICS
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- From Fibrosis to Sclerosis: Mechanisms of Glomerulosclerosis in Diabetic Nephropathy
- (2008) Y. Qian et al. DIABETES
- Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis
- (2008) Leigh A. Jania et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
- (2008) Tianxin Yang et al. PPAR Research
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now